Recent advances in artificial intelligence have enabled a new generation of companies and products that are poised to change healthcare forever. From drug discovery to early disease detection, AI is shaping a future where care is personalized, preemptive, and affordable.
Biocogniv enables a key part of this future by combining laboratory medicine, state-of-the-art AI, and evidence-based acute care, to reduce preventable hospital deaths, morbidities, and cost of care.
Location: United States, Vermont, South Burlington
Employees: 1-10
Total raised: $2.7M
Founded date: 2019
Investors 5
| Date | Name | Website |
| - | Hula | hulalakesi... |
| 25.03.2022 | Breyer Cap... | breyercapi... |
| 08.04.2021 | Y Combinat... | ycombinato... |
| - | 1984 Ventu... | 1984.vc |
| - | Inflect He... | inflecthea... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 31.08.2020 | Seed | $2.7M | - |
Mentions in press and media 2
| Date | Title | Description | Source |
| 27.07.2022 | Biocogniv Powers UTMB’s Award-Winning COVID-19 Program | University of Texas Medical Branch pathologists increased throughput & lab interpretation volume... | einpresswi... |
| 27.08.2020 | Here are the 197 tech startups from Y Combinator’s Summer 20... | We wrote about Y Combinator (YC) back in June after the startup incubator relaunched its Startup Sch... | techstartu... |